Detailed bladder cancer immunoprofiling reveals new clues for immunotherapeutic strategies
Nicole Viveiros(Instituto Português de Oncologia Francisco Gentil), Cármen Jerónimo(Universidade do Porto), Cintia Palu(Kymab (United Kingdom)), Cecilia Deantonio(Kymab (United Kingdom)), Rui Henrique(Universidade do Porto), Mariana Cantante(Instituto Português de Oncologia Francisco Gentil), Richard C.A. Sainson(Io Therapeutics (United States)), Bianca C. T. Flores(Instituto Português de Oncologia Francisco Gentil), João Lobo(Universidade do Porto), Cláudia Martins‐Lima(Instituto Português de Oncologia Francisco Gentil), Paula Lopes(Instituto Português de Oncologia Francisco Gentil)
Cited by 24
Related Papers
Integrative epigenetic taxonomy of primary prostate cancer
|Nature Communications|2018|167
Human Germ Cell Tumors are Developmental Cancers: Impact of Epigenetics on Pathobiology and Clinic
|International Journal of Molecular Sciences|2019|141
Data Sharing Under the General Data Protection Regulation
|Hypertension|2021|136
Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours
|Nature Reviews Urology|2020|112
<scp>WHO</scp> 2022 landscape of papillary and chromophobe renal cell carcinoma
|Histopathology|2022|112